|
Dr David Fyfe, a 30-year veteran of the global chemical and engineering industries, joined CDT as Chairman of the Board of Directors and Chief Executive Officer in September 2000.
He is experienced in driving commercial businesses and has extensive expertise in negotiating joint ventures, acquisitions and partnerships. Previous positions include senior executive roles in companies on both sides of the Atlantic, including ICI and BF Goodrich.
Dr Fyfe spent three years as CEO of Harris Speciality Chemicals (HSC), headquartered in Jacksonville, FL, USA. This $250 million turnover company had 900 employees, seven manufacturing plants in the U.S., and 11 locations in Europe and Asia. At HSC, Fyfe led a very successful turnaround and subsequent sale of the company to SKW - part of Germany's Viag Group - on behalf of Kelso & Company, one of the principal investors in CDT.
With a BA and MA from Cambridge University in Natural Sciences and a PhD for a dissertation in electrochemistry, Fyfe has chaired and taken part in a number of industry focused government bodies. He has chaired the UK Chemical Industries Association Business and Trade Board, was a member of the UK Department of Trade and Industry's deregulation taskforce for the chemical and pharmaceutical industries and Vice Chairman of the UK CBI Northern Region. | 